⌘K

Home/Filings/4/0000899243-20-014899

4//SEC Filing

Bogle Grant C. 4

Accession 0000899243-20-014899

CIK 0001571498other

View on SEC.gov Company Profile

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 4:16 PM ET

Size

5.3 KB

Accession

0000899243-20-014899

Insider Transaction Report

Form 4

Period: 2020-05-29

Epizyme, Inc.EPZM

Director

Transactions

Award
Stock Option (Right to Buy)
2020-05-29+14,013→ 14,013 total
Exercise: $17.55Exp: 2030-05-28→ Common Stock (14,013 underlying)

Footnotes (1)

[F1]This option will vest in full on May 29, 2021, subject to Reporting Person's continued service as a director. In the event of a change in control of the Issuer, the option will become exercisable in full.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Epizyme, Inc.

CIK 0001571498

Entity typeother

Related Parties

1

filerCIK 0001646675

Filing Metadata

Form type: 4
Filed: Jun 1, 8:00 PM ET
Accepted: Jun 2, 4:16 PM ET
Size: 5.3 KB

View on SEC.gov